aka Scenesse · Melanotan I · Afamelanotide · EPT1647
Open any panel for the full data
Afamelanotide is a synthetic alpha-melanocyte stimulating hormone (alpha-MSH) analog approved by the FDA for erythropoietic protoporphyria (EPP). It stimulates melanin production, providing photoprotection for patients with EPP. It is administered as a controlled-release subcutaneous implant.
Third-party creator videos and discussion, surfaced for research context. Amino Axiom does not endorse creator claims.
Episode 56 - 🏥💉Exploring Afamelanotide, a Vitiligo Study | The Future of Dermatology Podcast
Vitiligo trials of SCENESSE® -- Lee Thomas and Dr Philippe Wolgen, Part 2
Proud to represent La Réunion at #EADV 2025, during the Free Communications III (Pigmentary disorders) session, chaired by Prof Ashraf Badaw
Photosensitive skin conditions can result in cutaneous and systemic symptoms that can have a marked effect on quality of life due to ubiquit
📌 Soffri di #vitiligine? Scopri di più sulla sperimentazione clinica Clinuvel. Requisiti di accesso: • Presenza di vitiligine su viso e cor